Repression by RAZ of Epstein-Barr virus bZIP transcription factor EB1 is dimerization independent

Journal of General Virology

Volumn 77, Issue 7, 1996, Pages 1529-1536

  Segouffin, Carine ^a   Gruffat, Henri ^a   Sergeant, Alain ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HETEROGENEOUS NUCLEAR RNA; HYBRID PROTEIN; PROTEIN P53; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; DNA BINDING; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS INACTIVATION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

EID: 0029890066     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-7-1529     Document Type: Article

References (31)

1. Buisson, M., Manet, E., Trescol-Biemont, M.-C., Gruffat, H., Durand, B. & Sergeant, A. (1989). The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. Journal of Virology 63, 5276-5284.
2. Chang, Y., Dong, D., Hayward, G. & Hayward, S. (1990). The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. Journal of Virology 64, 3358-3369.
3. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. & Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO Journal 5, 3243-3249.
4. Cho, M.-S. & Tran, V.-M. (1993). A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1. Virology 194, 838-842.
5. Countryman, J. & Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences, USA 82, 4085-4089.
6. Countryman, J. K., Jenson, H., Grogan, E. & Miller, G. (1989). A 2·7-kb rearranged DNA fragment from Epstein-Barr virus capable of disruption of latency. Cancer Cells 4, 517-523.
7. Farrell, P. J., Rowe, D. T., Rooney, C. M. & Kouzarides, T. (1989). Epstein-Barr virus BZLF1 transactivator specifically binds to a consensus AP-1 site and is related to cFos. EMBO Journal 8, 127-132.
8. Fixman, E. D., Hayward, G. S. & Hayward, S. D. (1995). Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. Journal of Virology 69, 2998-3006.
9. Flemington, E. & Speck, S. H. (1990a). Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proceedings of the National Academy of Sciences, USA 87, 9459-9463.
10. Flemington, E. & Speck, S. H. (1990b). Autoregulation of Epstein-Barr virus putative lytic cycle switch gene BZLF1. Journal of Virology 64, 1227-1232.
11. Furnari, F., Zacny, V., Quilivan, B., Kenney, S. & Pagano, J. (1994). RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. Journal of Virology 68, 1827-1836.
12. Giot, J.-F., Mikaelian, I., Buisson, M., Manet, E., Joab, I., Nicolas, J.-C. & Sergeant, A. (1991). Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Research 19, 1251-1258.
13. Gorman, C., Moffat, L. & Howard, B. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2, 1044-1051.
14. Gruffat, H., Manet, E., Rigolet, A. & Sergeant, A. (1990). The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein. Nucleic Acids Research 18, 6835-6843.
15. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S. & Kenney, S. C. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-κB. Molecular and Cellular Biology 14, 1939-1948.
16. Hardwick, J. M., Lieberman, P.M. & Hayward, D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. Journal of Virology 62, 2274-2284.
17. Kelleher, C., Paterson, R., Dreyfus, D., Streib, J., Xu, J., Takase, K., Jones, J. & Gelfand, E. (1995). Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208, 685-695.
18. Kouzarides, T., Packhman, G., Cook, A. & Farrell, P. (1991). The BZLF1 protein of EBV has a coiled dimerisation domain without a heptad repeat but with homology to the C/EBP leucine zipper. Oncogene 6, 195-204.
19. Liebowitz, D. & Kieff, E. (1993). Epstein-Barr virus. In The Human Herpesviruses, pp. 107-172. Edited by B. Roizman, R. J. Whitley & C. Lopez. New York: Raven Press.
20. Manet, E., Gruffat, H., Trescol-Biemont, M.-C., Moreno, N., Chambard, P., Giot, J.-F. & Sergeant, A. (1989). Epstein-Barr bicistronic mRNAs generated by facultative splicing code for two transcriptional transactivators. EMBO Journal 8, 1819-1826.
21. Mikaelian, I., Drouet, E., Marechal, V., Denoyel, G., Nicolas, J.-C. & Sergeant, A. (1993a). The DNA-binding domain of two bZIP transcription factors, the Epstein-Barr virus switch gene product EB1 and Jun, is a bipartite nuclear targeting sequence. Journal of Virology 67, 734-742.
22. Mikaelian, I., Manet, E. & Sergeant, A. (1993b). The bZIP motif of the Epstein-Barr virus (EBV) transcription factor EB1 mediates a direct interaction with TBP. Compte Rendu de l'Academie des Sciences 316, 1424-1432.
23. Prang, N., Wolf, H. & Schwarzmann, F. (1995). Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1. Journal of Virology 69, 2644-2648.
24. Rooney, C., Rowe, D., Ragot, T. & Farrell, P. (1989). The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. Journal of Virology 63, 3109-3116.
25. Schepers, A., Pich, D. & Hammerschmidt, W. (1993). Transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO Journal 12, 3921-3929.
26. Sista, N. D., Pagano, J. S., Liao, W. & Kenney, S. (1993). Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proceedings of the National Academy of Sciences, USA 90, 3894-3898.
27. Sista, N. D., Barry, C., Sampson, K. & Pagano, J. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARα and RXRα. Nucleic Acids Research 23, 1729-1736.
28. Takada, K., Shimizu, N., Sakuma, S. & Ono, Y. (1986). Transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. Journal of Virology 57, 1016-1022.
29. Urier, G., Buisson, M., Chambard, P. & Sergeant, A. (1989). The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. EMBO Journal 8, 1447-1453.
30. Zhang, Q., Gutsch, D. & Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Molecular and Cellular Biology 14, 1929-1938.
31. zur Hausen, H., O'Neill, F. J., Freese, U.K. & Hecker, E. (1978). Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature 272, 373-375.